aod9604 slu pp 332 bloend AOD-9604 Dosage Guide: Complete Protocol for Safe Administration SLU-PP-332 Research Overview | Scientific

In conclusion, multiple clinical studies have suggested that the peptide may significantly induce lipolysis and possibly prevent lipogenesis by mimicking natural hGH

However, large obesity trials did not show clinically meaningful weight loss, and regulators have raised concerns about immunogenicity and safety data gaps, which is why Better Med Spa restricts its use to clearly informed, highly selected clients

Weight regulation : In mouse studies, systemic administration produced a progressive reduction in body weight and up to a ~35% decrease in white adipose tissue mass

NNMT is overexpressed in adipose tissue of obese subjects, and its inhibition has been explored as a strategy to modulate methyl group flux and NAD+ precursor availability

Peptides like this one are fragile molecules, and an injectable, subcutaneous form is generally the most predictable way to deliver a known, stable amount into the body